- €321.22m
- €634.66m
- €51.32m
- 47
- 63
- 65
- 62
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41.6 | 44.6 | 46.3 | 47.8 | 51.3 |
Cost of Revenue | |||||
Gross Profit | 32.2 | 33.1 | 34.9 | 37.5 | 47.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.14 | 29.6 | -0.786 | -16.2 | 9.64 |
Operating Profit | 34.4 | 15 | 47.1 | 64 | 41.7 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 21.1 | 9.66 | 46.5 | 96 | 34.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21.3 | 9.24 | 45.7 | 90.7 | 33.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 21.3 | 9.24 | 45.7 | 90.7 | 33.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 21.3 | 9.25 | 45.7 | 90.7 | 33.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.32 | 1.4 | 6.92 | 13.7 | 5.13 |
Dividends per Share |